ÂÜÀòÂÒÂ×

The Scientific Team at Mana.bio is responsible for advancing the development of Lipid Nanoparticle (LNP) technology for oligonucleotide therapies. This includes conducting cutting-edge research, optimizing formulations, and ensuring the scientific rigor and innovation required to propel mRNA-based therapeutics, vaccines, and gene therapies from concept to clinical application.